OPKO Health Acquires Prolor Biotech for $480 Million

Prolor Biotech develops proprietary versions of proteins already approved for medical therapy, such as human growth hormone, and helps with commercialization.

Shelly Appelberg
Shelly Appelberg
Send in e-mailSend in e-mail

Comments